![]() | San Francisco Neurological Society
|
![]() Dinner Meeting Thursday May 28, 2009Hotel Monaco - 6:15 - 7:00 Registration and Wine Reception " Intracerebral Hemorrhage: New Approaches toan Old Disease"Speaker: J. Claude Hemphill III, MD, MAS, University of California, San Francisco & San Francisco General Hospital Moderator: Kern H. Guppy, MD, PhD, The Permanente Medical Group, Sacramento, SFNS President Intracerebral hemorrhage remains without a proven treatment. Recent randomized clinical trials have provided new insights into ICH management. However, care remains heterogeneous and nihilism is common. Come explore whether you are doing 'the right thing' for your acute ICH patients. Dr. Claude Hemphill is Associate Professor of Clinical Neurology and Neurological Surgery at the University of California, San Francisco and Director of Neurocritical Care at San Francisco General Hospital. He has been on faculty at UCSF since 1996 and his clinical and research interests have included (1) intracerebral hemorrhage and (2) advanced neuromonitoring in neurocritical care. He has also received a Masters Degree in Clinical Research. In 2001, he developed the ICH Score, which is the most widely used clinical grading scale for acute intracerebral hemorrhage (ICH). His work has included a prospective study of secondary brain insults in which he identified that fever independently worsens outcome after ICH; he also reported the first use of brain tissue oxygen monitoring specifically in a group of ICH patients. He is also co-director of the UCSF Brain and Spinal Injury Center (at SFGH) whose mission is to promote collaborative basic, translational, and clinical research regarding mechanisms of injury and repair from acute central nervous system injuries. EDUCATIONAL OBJECTIVES: Upon completion of this lecture participants should be able to: 1. Review the current management of intracerebral hemorrhages 2. Present evidence-based treatment for intracerebral hemorrhages from clinical trials. 3. Understand how to reduce incidence of intracerebral hemorrhages in patients on anticoagulants. Who Should Attend? Neurologists, neurosurgeons, neuroradiologists, residents and other physicians interested in research and clinical advances in the neurosciences. Accreditation Statement Designation Statement Hotel Monaco, 501 Geary Street on the corner of Taylor Street, San Francisco, CA, Telephone: For more information: The San Francisco Neurological Society is an organization of physicians with a dedicated interest in the clinical neurosciences. The Society is committed to the continuing medical education of its members and has an obligation to its members and to the public to provide ongoing educational programs designed to improve patient care and foster scholarly activity in the neurosciences. This obligation includes not only imparting to the membership an increased understanding of neurological diseases through lectures on clinical and basic research, but also making them aware of community and public health issues related to neurological illnesses and preventive medicine. The Society is a CMA-accredited provider. Physicians attending this course may report up to 8 hours of Category 1 credit toward the California Medical Association Certificate in Continuing Medical Education and the American Medical Associations Physicians Recognition Award.
|